Bibliographic Info
GuidelineGuidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
Year of Publication2015
Issuing InstitutionWorld Health Organization
Recommendation
Status
Maintained
Recommended in favor
Strong
Certainty of evidence
Low
SECOND-LINE ANTIVIRAL THERAPIES FOR THE MANAGEMENT OF TREATMENT FAILURE FOR CHRONIC HEPATITIS B. In persons with confirmed or suspected antiviral resistance (i.e. history of prior exposure or primary non-response) to lamivudine, entecavir, adefovir or telbivudine, a switch to tenofovir is recommended
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection.
Year2024
InstitutionWHO